Straumann rises after Q3 sales modestly beat expectations
** Shares in Swiss dental implants maker Straumann STMN.S rise 2.7% in pre-market indications after Q3 revenue slightly beat expectations driven by all regions
** The company reported Q3 revenue of 667.1 million Swiss francs ($805.1 million) versus a Vara consensus of 662.3 million
** North America sales grew 7.5%, with the broker Vontobel saying the region "performed as expected" and continued its positive trajectory despite a soft demand backdrop
** The group confirmed its full-year outlook
** The stock has gained 4.5% YTD
($1 = 0.8286 Swiss francs)